Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Paul Pinsky

Paul F Pinsky PhD

Acting Chief, Early Detection Branch, National Cancer Institute

Dr. Paul Pinsky is acting chief of the Early Detection Research Branch. He has a background in statistics, epidemiology and mathematical modeling. He has worked extensively with data from the Branch's two large screening trials, the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and the National Lung Screening Trial (NLST). His research pertaining to the trials has dealt with evaluating the direct and indirect effects of screening, examining factors that affect screening efficacy, and evaluating the burdens of screening.

Dr. Pinsky has also worked in the fields of mathematical modeling, especially of the natural history of cancer, epidemiology and statistical methods. He has a PhD in applied mathematics and an MPH in epidemiology.

Recent Contributions to PracticeUpdate:

  1. The Controversy Over PSA Testing Stumbles On
  2. Reevaluating PSA Testing Rates in the PLCO Trial

Recently Updated